SinoMab BioScience to raise HKD 1.75b in IPO
Hong Kong-based biopharmaceutical company SinoMab BioScience Ltd. intends to raise as much as HKD 1.75 billion in an initial public offering on the Hong Kong Stock Exchange.
3 Dividend Stocks From The Pearl River Delta
Within China, the Pearl River Delta region is an economic powerhouse in its own right. It is home to multiple major companies. Investing in these companies could benefit long-term investors. Here are 3 attractive dividend stocks with strong exposure in this region…
3 Dividend Stocks to Fortify Your Portfolio
At EastMoneyStocks, we recognise that not every investor is interested in buying penny stocks. As such, there is a role for dividend stocks to play in the portfolio of most investors, especially in times of economic uncertainty.